Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$6,125,489
+$1,433,743 QoQ
Shares Held
5,107
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.78%
of 13F equity value
Holder Rank
#1,559
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEDDOCK CAPITAL ADVISORS, LLC holds $14,670,442 across 9 Drug Manufacturers - General names. LLY ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
5,107 | $6,125,489 | |
| 2 | JNJ |
Johnson & Johnson
|
9,928 | $2,521,414 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
18,257 | $2,306,589 | |
| 4 | MRK |
Merck & Co., Inc.
|
9,129 | $1,173,076 | |
| 5 | PFE |
Pfizer Inc
|
34,780 | $837,502 | |
| 6 | ABBV |
AbbVie Inc.
|
2,850 | $717,174 | |
| 7 | NVS |
Novartis AG
|
2,632 | $412,487 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,264 | $303,311 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,125,489 | 5,107 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $4,691,746 | 5,101 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $5,506,660 | 5,124 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $3,909,612 | 5,124 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $3,994,311 | 5,124 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $4,231,962 | 5,124 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,937,972 | 5,101 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $4,519,179 | 5,101 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $4,618,343 | 5,101 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $3,973,041 | 5,107 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,976,972 | 5,107 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,743,122 | 5,107 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,390,391 | 5,097 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,750,411 | 5,097 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,864,686 | 5,097 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $1,654,258 | 5,116 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,658,760 | 5,116 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,465,068 | 5,116 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,413,141 | 5,116 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,182,051 | 5,116 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,173,076 | 5,111 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $981,739 | 5,255 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $887,254 | 5,255 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $778,733 | 5,261 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $879,512 | 5,357 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $743,123 | 5,357 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||